Chemomab Therapeutics Ltd
CMMB
Detailliertes Diagramm anzeigen
1.530USD
+0.080+5.54%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
37.68MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+5.54%
5 Tage
-1.27%
1 Monat
-15.45%
6 Monate
-60.96%
Seit Jahresbeginn
-7.25%
1 Jahr
-81.69%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Kein Aktien-Score verfügbar aufgrund unzureichender Daten.
Chemomab Therapeutics Ltd Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Gesamteinnahmen
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Chemomab Therapeutics Ltd Informationen
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
BörsenkürzelCMMB
UnternehmenChemomab Therapeutics Ltd
CEOMor (Adi)
Websitehttps://www.chemomab.com/
Verwandte Finanzinstrumente
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%Beliebte Symbole
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68474.150
-1495.980 (-2.14%)
282.580
+22.390 (+8.61%)
2017.520
-34.210 (-1.67%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
